Endocrinology, Diabetes & Metabolism Doctors in Bloomfield Hills, MI Accepting Medicare

4 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 4

Khachorndej Vibhasiri, M.D Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 732 Brookwood Walke, Bloomfield Hills, MI 48304 Phone: 248-644-6360    Fax: 248-644-6360

Anjana Myneni, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 43494 Woodward Ave, Suite 208, Bloomfield Hills, MI 48302 Phone: 248-335-7740    Fax: 248-338-7979

Dr. George Grunberger, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 43494 Woodward Ave, Ste 208, Bloomfield Hills, MI 48302 Phone: 248-335-7740    Fax: 248-338-7979

Dr. David M Bradlee, D.O. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 43902 Woodward Ave, Suite 240, Bloomfield Hills, MI 48302 Phone: 248-454-7650    Fax: 248-454-9794

News Archive

Fish oil, soluble fiber and antioxidants reduces need for traditional ulcerative colitis treatment

According to a study published in the American Gastroenterological Association (AGA) journal Clinical Gastroenterology and Hepatology, a nutritionally complete oral supplement enriched with fish oil, soluble fiber and antioxidants reduces reliance on traditional therapies for people with ulcerative colitis.

Caring for a family member with a serious heart ailment may increase your risk of cardiac disease

Researchers examined heart risk factors in family members of cardiac patients and found that those who provided all or most of a patient's care had higher levels of risk factors for heart disease than non-caregivers and those who reported higher caregiver strain after six months were more likely to be depressed than those who provided less or no care.

Opexa Therapeutics to present data from Phase 2b TERMS clinical trial for Tovaxin at 62nd AAN meeting

Opexa Therapeutics, Inc., a company developing a novel T-cell therapy for multiple sclerosis (MS), announced today that the Company has been selected to present key efficacy data at the upcoming American Academy of Neurology (AAN) 62nd Annual Meeting to be held in Toronto, Canada.

Metabolic syndrome linked to increased risk of primary liver cancers

Incidence rates of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) have increased in the U.S. This population-based study publishing in the August issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, found that metabolic syndrome significantly increases risk of developing these primary liver cancers.

Read more Medical News

› Verified 5 days ago